TrialBMC endocrine disorders2021

The differences between insulin glargine U300 and insulin degludec U100 in impact on the glycaemic variability, arterial stiffness and the lipid profiles in insulin naïve patients suffering from type two diabetes mellitus - outcomes from cross-over open-label randomized trial.

Pavle Vrebalov Cindro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.